BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Veneti S, Tziomalos K. Is there a role for glucagon-like peptide-1 receptor agonists in the management of diabetic nephropathy? World J Diabetes 2020; 11(9): 370-373 [PMID: 32994865 DOI: 10.4239/wjd.v11.i9.370]
URL: https://www.wjgnet.com/1948-9358/full/v11/i9/370.htm
Number Citing Articles
1
Anna Psyllaki, Konstantinos Tziomalos. New perspectives in the management of diabetic nephropathyWorld Journal of Diabetes 2024; 15(6): 1086-1090 doi: 10.4239/wjd.v15.i6.1086
2
Daniel Yuan, Harman Sharma, Anirudh Krishnan, Venkat N. Vangaveti, Usman H. Malabu. Effect of glucagon‐like peptide 1 receptor agonists on albuminuria in adult patients with type 2 diabetes mellitus: A systematic review and meta‐analysisDiabetes, Obesity and Metabolism 2022; 24(9): 1869 doi: 10.1111/dom.14776